Oracle, AstraZeneca Partner to Explore AI for Clinical Trial Recruitment
Bitget2026/10/20 03:51- Oracle entered a nonbinding agreement with AstraZeneca to explore AI-enabled healthcare applications using real-world data.
- The collaboration aims to improve clinical trial recruitment by helping clinicians identify eligible patients sooner.
- The companies plan to accelerate evidence generation and bring research insights into routine patient care.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese stocks closed down 2.65%
AI trading concerns reignite: global bond markets see renewed safe-haven buying, funds flow back into U.S. Treasuries
Weakness in the stock market has triggered safe-haven buying, driving gains in US Treasuries, the Japanese yen, and the Swiss franc. Yields on US Treasuries have declined across the board, with the 30-year yield reaching its lowest level since late September.
Unafraid of the electric vehicle downturn: General Motors (GM.US) makes a bold bet on lithium-manganese-based batteries, wagering on the next generation of affordable electric vehicles
General Motors (GM.US) remains undeterred by the electric vehicle market downturn in recent years and is moving forward with a brand new EV project, aiming to launch a new battery-powered mainstream SUV in approximately three years.
WTI Price Forecast: Advances above mid-$98.00s as bullish setup backs additional gains
Crypto prices
More
